Utilizing a filamentous fungus in the gut microbiome may provide a new strategy for treating metabolic dysfunction-associated steatohepatitis (MASH). Researchers have developed an innovative method ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback